MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The progression rate of sporadic adult-onset cerebellar ataxia : 1-year follow up study

    PW. Ko, HW. Lee, K. Kang (Daegu, Republic of Korea)

    Objective: To assess progression rate of the sporadic adult-onset ataxia (SAOA) and usefulness of well-known evaluation tools. Background: The sporadic adult-onset ataxia (SAOA) is a…
  • 2019 International Congress

    The applicability of the Scale for Assessment and Rating of Ataxia (SARA) in toddlers

    S. Polet, A. Tadema, S. Hbrahimgel, M. Vanden Berg, M. Kuiper, R. Brandsma, D. Sival (Groningen, Netherlands)

    Objective: In healthy toddlers (2-4 years of age), we aimed to evaluate: 1. the feasibility of SARA performances and 2. the reliability of SARA sub-score…
  • 2019 International Congress

    Another mitochondrial disease mimic: Two Case reports of adult riboflavin transporter deficiency (RTD) type 2 with muscle adenosine monophosphate (AMP) deaminase deficiency

    L. Zhang, D. Thyagarajan (Melbourne, Australia)

    Objective: To present two rare cases of RTD type 2 with co-existing AMP deaminase deficiency. Background: RTD, formerly known as Brown-Vialetto-Van Laere syndrome, is a…
  • 2019 International Congress

    Huntington Disease-Like 2: A Case Presentation and Review of the Literature

    J. Pleen, V. Saini, N. Doher, R. Walker, V. Singh (Kansas City, KS, USA)

    Objective: To present a case of Huntington Disease-Like 2 (HDL2). HDL2 is rare and phenotypically similar to Huntington’s Disease (HD). However the gene, chromosome, and…
  • 2019 International Congress

    Progressive Myoclonus Ataxia: An International Database

    S. Vd Veen, T. de Koning, D. Sival, M. Tijssen (Groningen, Netherlands)

    Objective: Our aim is to create an international database for patients suffering from the rare syndrome of progressive myoclonus ataxia (PMA), containing their clinical, electrophysiological…
  • 2019 International Congress

    LY-341,495, an mGlu2/3 antagonist, abolishes the anti-dyskinetic and anti-psychotic effects of the mGlu2/3 orthosteric agonist LY-354,740 in the MPTP-lesioned marmoset

    A. Hamadjida, S. Nuara, J. Gourdon, P. Huot (Montreal, QC, Canada)

    Objective: We aim to determine the effect of orthosteric blockade of metabotropic glutamate 2 and 3 (mGlu2/3) receptors with LY-341,495 on the anti-dyskinetic and anti-psychotic…
  • 2019 International Congress

    Safinamide reduces membrane excitability and synaptic transmission of striatal spiny projection neurons in a rat model of Parkinson’s disease

    A. Tozzi, M. Sciaccaluga, P. Mazzocchetti, G. Bastioli, V. Ghiglieri, B. Picconi, C. Caccia, C. Keywood, G. Padoani, P. Calabresi (Perugia, Italy)

    Objective: The effect of safinamide (saf) on the electrical membrane properties and both excitatory and inhibitory synaptic transmission of striatal spiny projection neurons (SPNs) was…
  • 2019 International Congress

    Shedding light on the relationship between dyskinesia assessed by a wearable device and impulsive compulsive behaviour in Parkinson’s disease

    F. Morgante, A. de Angelis, C. Siri, M. Horne, A. Leake, D. Paviour, M. Edwards, L. Ricciardi (London, United Kingdom)

    Objective: To evaluate the relationship between the presence of dyskinesia objectively detected using a wearable device and the presence of active and past impulsive compulsive…
  • 2019 International Congress

    The role of attention in functional movement disorders

    A. Huys, P. Haggard, K. Bhatia, M. Edwards (London, United Kingdom)

    Objective: Identify where the attentional focus naturally lies in functional movement disorders and evaluate which abnormal attentional foci contribute to symptom generation. The ultimate aim…
  • 2019 International Congress

    Neuropsychological profile of patients with functional movement disorders

    G. Vechetova, T. Nikolai, M. Slovak, Z. Hanzlikova, M. Vranka, E. Bolcekova, T. Teodoro, E. Ruzicka, M. Edwards, T. Serranova (Prague, Czech Republic)

    Objective: Our objective was to assess cognitive functioning in patients with functional movement disorders (FMD) with main focus on the attentional aspects. Background: Although the…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley